Navigation Links
Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market
Date:5/21/2013

NEW YORK, May 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

http://www.reportlinker.com/p01188015/Changing-Regulatory-and-Reimbursement-Scenario-for-Medical-Devices-in-the-US-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

 

Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

 

Summary

 

GBI Research's report "Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market" looks at the regulatory landscape and reimbursement scenario in the US for four medical device markets: cardiovascular devices, neurostimulation devices, diagnostic imaging devices and endoscopy devices. The report provides comprehensive information on establishment registration, medical device listing, Premarket Notification (510k) or Premarket Approval (PMA), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, labeling requirements, and Medical Device Reporting (MDR). The report also reviews the reimbursement scenario in these medical device markets. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

 

Scope

 

- The report analyzes the regulatory and reimbursement scenario for medical devices in the US.

- Information on the regulatory landscape in the US: establishment registration, medical device listing, Premarket Notification (510k) or PMA, IDE for clinical studies, QS regulation, labeling requirements, and MDR.

- Information on reimbursement coverage in the US for cardiovascular devices, neurostimulation devices, diagnostic imaging devices and endoscopy devices.

- Annualized market revenue data, forecast to 2018, for the transcatheter heart valves market, left ventricular assist devices market and endoscopy devices market.

- Qualitative analysis of key trends in the US regulatory and reimbursement landscape.

 

Reasons to buy

 

- Develop business strategies by understanding the reimbursement trends in the US medical devices market.

- Design and enhance your product development, marketing, and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify, understand and capitalize on the next big thing in the US medical devices market landscape.

- Make more informed business decisions from the insightful and in-depth analysis of the US medical devices market and the factors shaping it.

 

 

 

Table of Contents

 

1 Table of Contents 5

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 7

3 Overview of the Healthcare Reform Bill 8

4 Regulatory Landscape in the US 13

4.1 Overview of Medical Device Regulation 13

4.1.1 Establishment Registration 15

4.1.2 Medical Device Listing 15

4.1.3 New Medical Device Approval Process 16

4.1.4 Quality System Regulation/Good Manufacturing Practices 21

4.1.5 Labeling 21

4.1.6 Medical Device Reporting 22

5 Changing Reimbursement Scenario in the Medical Device Market 24

5.1 Cardiovascular Devices 24

5.1.1 Reimbursement Coverage for Transcatheter Aortic Valve Replacement 24

5.1.2 Reimbursement Coverage for Artificial Hearts and Related Devices 26

5.1.3 Reimbursement Coverage for Percutaneous Transluminal Angioplasty 28

5.2 Neurostimulation Devices 30

5.2.1 Reimbursement Coverage for Transcutaneous Electrical Nerve Stimulation 30

5.3 Diagnostic Imaging Devices 32

5.3.1 Reimbursement Coverage for Magnetic Resonance Imaging 32

5.3.2 Reimbursement Coverage for Positron Emission Tomography Scans 33

5.3.3 Reimbursement Cuts for Diagnostic Imaging Services 33

5.4 Endoscopy Devices 34

5.4.1 Reimbursement Coverage for Capsule Endoscope Systems 34

6 Appendix 38

6.1 Definitions 38

6.1.1 Cardiovascular Devices 38

6.1.2 Diagnostic Imaging 38

6.1.3 Neurostimulation Devices 38

6.1.4 Endoscopy Devices 38

6.2 Acronyms 38

6.3 Sources 39

6.4 Research Methodology 41

6.4.1 Secondary Research 41

6.4.2 Primary Research 41

6.4.3 Models 42

6.4.4 Forecasts 42

6.4.5 Expert Panels 42

6.5 Contact Us 42

6.6 Disclaimer 42

 

 

 

List of Tables

 

Table 1: Food and Drug Administration, US, Classification Regulations 16

Table 2: Food and Drug Administration, US, Device Labeling 21

Table 3: Food and Drug Administration. US, Reporting Requirements for Manufacturers 22

Table 4: Food and Drug Administration, US, Reporting Requirements for User Facilities 22

Table 5: Transcatheter Heart Valves Market, US, Revenue Forecast ($m), 2012-2019 25

Table 6: Left Ventricular Assist Devices Market, US, Revenue Forecast ($m), 2012-2019 27

Table 7: Capsule Endoscope Systems Market, US, Revenue Forecast ($m), 2012-2019 36

 

 

 

List of Figures

 

Figure 1: Key Healthcare Reform Provisions, US, 2010 - A 8

Figure 2: Key Healthcare Reform Provisions, US, 2010 - B 9

Figure 3: Key Healthcare Reform Provisions, US, 2010 - C 9

Figure 4: Key Healthcare Reform Provisions, US, 2010 - D 10

Figure 5: Key Healthcare Reform Provisions, US, 2010 - E 10

Figure 6: Key Healthcare Reform Provisions, US, 2010 - F 11

Figure 7: Key Healthcare Reform Provisions, US, 2010 - G 11

Figure 8: Key Healthcare Reform Provisions, US, 2010 - H 12

Figure 9: Food and Drug Administration, US, Organizational Structure 13

Figure 10: Food and Drug Administration, US, Basic Regulatory Requirements 14

Figure 11: Food and Drug Administration, US, Regulations for Approval of New Medical Device 18

Figure 12: Transcatheter Heart Valves Market, US, Revenue Forecast ($m), 2012-2019 25

Figure 13: Left Ventricular Assist Devices Market, US, Revenue Forecast ($m), 2012-2019 27

Figure 14: Capsule Endoscope Systems Market, US, Revenue Forecast ($m), 2012-2019 36

 

 

 

To order this report:

Medical_Imaging Industry: Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market

 

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NFLPA and THERAPEARL, LLC Partner to Provide Athletes with Game Changing Innovations in Hot and Cold Pack Therapy
2. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
3. New Knee Implant Is Changing The Way Patients And Surgeons View Revision Hinged Knee Replacement
4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
5. Hologic to Showcase Game-Changing Breast Tomosynthesis Technology and Other Product Innovations at the European Congress of Radiology in Vienna
6. Frost & Sullivan Recognizes KAERs Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
7. Frost & Sullivan Honours CapsoVision for CapsoCam SV-1, its Game-changing Gastrointestinal Capsule Endoscope
8. FDA Cleared ChromaGen Lenses Are A Life-Changing Aid For People Struggling With Dyslexia And Other Reading Problems
9. Thoma & Sutton Eye Care Launches ChromaGen Life-Changing Lens Technology
10. ChromaGen Launches Life-Changing Lens Technology In Houston, Texas
11. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... February 12, 2016 ... vermerkt)   http://www.sedar.com ) und ... abrufbar.    --> http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... heute seinen Konzernabschluss des zweiten Quartals ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... Valentine’s Day is nearly upon us, and most singles could probably ... flawless hair, and a sparkling personality are all well and good, but if somebody ... home with Rover. (Actually, man’s best friend might not even want to be near ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
Breaking Medicine News(10 mins):